High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial.

TitleHigh-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial.
Publication TypeJournal Article
Year of Publication2013
AuthorsSchaich M, Parmentier S, Kramer M, Illmer T, Stölzel F, Röllig C, Thiede C, Hänel M, Schäfer-Eckart K, Aulitzky W, Einsele H, Ho AD, Serve H, Berdel WE, Mayer J, Schmitz N, Krause SW, Neubauer A, Baldus CD, Schetelig J, Bornhäuser M, Ehninger G
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology
Volume31
Issue17
Pagination2094-102
Date Published2013 Jun 10
Abstract

To assess the treatment outcome benefit of multiagent consolidation in young adults with acute myeloid leukemia (AML) in a prospective, randomized, multicenter trial.

DOI10.1371/journal.pone.0071968
Alternate JournalJ. Clin. Oncol.